Search Results - Gul Basaran
- Showing 1 - 5 results of 5
-
1
-
2
Quality of life and psychosocial challenges in metastatic breast cancer: the need for tailored interventions in Turkiye by Gul Basaran, Nuri Karadurmus, Fatma Bugdayci Basal, Violet Aroyo, Esra Savas, Ozge Fulya Ozturk Saglam, Pınar Gunay Aslan, Mahmut Gumus
Published in Future Science OA (2025-12-01)Get full text
Article -
3
Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial by Atakan Demir, Nil Molinas Mandel, Semra Paydas, Gökhan Demir, Özlem Er, Nazım Serdal Turhal, Sevil Bavbek, Yeşim Eralp, Pınar Mualla Saip, Emine Nilüfer Güler, Adnan Aydıner, Başak Oyan Uluç, Sadettin Kılıçkap, Necdet Üskent, Nuri Karadurmuş, Mehmet Ali Kaplan, Mustafa Teoman Yanmaz, Hacer Demir, Özkan Alan, Taner Korkmaz, Polat Olgun, Özlem Sönmez Uysal, Kadri Altundağ, Şeyda Gündüz, Meral Günaldı, Murat Sarı, İsmail Beypınar, Gül Başaran
Published in Balkan Medical Journal (2020-03-01)Get full text
Article -
4
Antibody–drug conjugate sequencing in HER2-positive metastatic breast cancer: Real-world outcomes of trastuzumab deruxtecan with and without prior T-DM1 exposure by Fatih Kemik, Taha Koray Şahin, Hakan Özçelik, Ahmet Sezer, Gül Başaran, Sakine Damla Açıkel Yüksel, Gizem Güney, İbrahim Yıldız, Özlem Er, Taner Korkmaz, Sedat Biter, Dilek Erdem, Salih Tünbekici, Ahmet Oruç, Ali Kaan Güren, Kerim Kaban, Musa Barış Aykan, Ömer Burak Ekinci, İlknur Deliktaş Onur, Ali Kalem, Oğuz Altunok, Mustafa Seyyar, Bünyamin Güney, Orhun Akdoğan, Melike Yazıcı, Nargiz Majidova, Sema Türker, Bahadır Köylü, Cevat İlteriş Kıkılı, Nazan Demir, Didem Tunalı, Şahin Laçin, Deniz Tural, Ahmet Bilici, Ertuğrul Bayram, Erdem Göker, Murat Araz, İbrahim Vedat Bayoğlu, Nil Molinas Mandel, Nuri Karadurmuş, Emir Çelik, Öztürk Ateş, Havva Yeşil Çınkır, Mesut Yılmaz, Rıza Umar Gürsu, Ozan Yazıcı, Devrim Çabuk, Deniz Can Güven, Fatih Selçukbiricik, Sercan Aksoy, Şeyda Gündüz
Published in Breast (2026-06-01)Get full text
Article -
5
Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study by Taha Koray Sahin, Fatih Kemik, Harun Muglu, Bedriye Acikgöz Yildiz, Sedat Biter, Salih Tunbekici, Ahmet Oruc, Ali Kaan Guren, Kerim Kaban, Halil Goksel Guzel, Cihan Erol, Musa Baris Aykan, Bahadir Koylu, Omer Burak Ekinci, Ilknur Deliktas Onur, Ali Kalem, Oguz Altunok, Mustafa Seyyar, Bunyamin Guney, Orhun Akdogan, Rashad Ismayilov, Fadime Sinem Ardic, Melike Yazici, Nargiz Majidova, Sema Turker, Ece Esin, Devrim Cabuk, Hatime Arzu Yasar, Arzu Oguz, Ozan Yazici, Riza Umar Gursu, Mesut Yılmaz, Havva Yesil Cinkir, Ozturk Ates, Emir Celik, Nuri Karadurmus, Umut Demirci, Banu Ozturk, Nil Molinas Mandel, Ibrahim Vedat Bayoglu, Murat Araz, Erdem Goker, Ertugrul Bayram, Dilek Erdem, Fatih Selcukbiricik, Gul Basaran, Ahmet Sezer, Gamze Gokoz Dogu, Yasemin Kemal, Ahmet Bilici, Seyda Gunduz, Deniz Can Guven, Sercan Aksoy
Published in Therapeutic Advances in Medical Oncology (2026-03-01)Get full text
Article
